Academic · Private company
Alliance Foundation Trials, LLC.
Track this companyFree. Adds Alliance Foundation Trials, LLC. to your Dealase workspace and tells you when its record changes.
Clinical trials2010 recruiting or active
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Clinical trials20
- Adjuvant Chemotherapy and Immunotherapy for Completely Resected Small Cell Lung CancerPHASE2 · RECRUITING · started Feb 12, 2026ClinicalTrials.gov NCT07149363 · fetched Nov 12, 2026
- Longitudinal Screening for Financial Hardship to Improve Outcomes in Patients With Advanced CancerNA · RECRUITING · started Jul 1, 2025ClinicalTrials.gov NCT06963723 · fetched Nov 12, 2026
- Atezolizumab Immunotherapy With or Without Tiragolumab for Patients With Unresectable Stage III NSCLCPHASE2 · ACTIVE_NOT_RECRUITING · started Dec 7, 2023ClinicalTrials.gov NCT05798663 · fetched Nov 12, 2026
- A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial CancerPHASE1_PHASE2 · RECRUITING · started Oct 20, 2021ClinicalTrials.gov NCT04486352 · fetched Nov 12, 2026
- Androgen Receptor Directed Therapy on Cognitive Function in Patients Treated With Darolutamide or EnzalutamidePHASE2 · COMPLETED · started Aug 17, 2021ClinicalTrials.gov NCT04335682 · fetched Nov 12, 2026
- CHIO3 Trial: CHemotherapy Combined With Immune Checkpoint Inhibitor for Operable Stage IIIA/B Non-Small Cell Lung CancerPHASE2 · ACTIVE_NOT_RECRUITING · started Mar 10, 2021ClinicalTrials.gov NCT04062708 · fetched Nov 12, 2026
- Study of Lenalidomide/Ixazomib/Dexamethasone/Daratumumab in Transplant-Ineligible Patients With Newly Diagnosed MMPHASE2 · ACTIVE_NOT_RECRUITING · started Oct 21, 2020ClinicalTrials.gov NCT04009109 · fetched Nov 12, 2026
- Study of Ibrutinib in Combination With Revlimid/Dexamethasone in Relapsed/Refractory Multiple MyelomaPHASE1 · COMPLETED · started Aug 29, 2019ClinicalTrials.gov NCT03702725 · fetched Nov 12, 2026
- Nivolumab in Patients With Advanced Non-Small Cell Lung Cancer and Pre-existing Autoimmune DiseasePHASE1 · TERMINATED · started Jun 27, 2019ClinicalTrials.gov NCT03656627 · fetched Nov 12, 2026
- Phase II Palbociclib +Ibrutinib in Mantle Cell LymphomaPHASE2 · ACTIVE_NOT_RECRUITING · started Sep 11, 2018ClinicalTrials.gov NCT03478514 · fetched Nov 12, 2026
- Atezolizumab Immunotherapy in Patients With Advanced NSCLCPHASE2 · COMPLETED · started Nov 1, 2017ClinicalTrials.gov NCT03102242 · fetched Nov 12, 2026
- Electronic Patient Reporting of Symptoms During Cancer TreatmentNA · COMPLETED · started Oct 30, 2017ClinicalTrials.gov NCT03249090 · fetched Nov 12, 2026
- Randomized, Open Label, Clinical Study of the Targeted Therapy, Palbociclib, to Treat Metastatic Breast CancerPHASE3 · ACTIVE_NOT_RECRUITING · started Jun 21, 2017ClinicalTrials.gov NCT02947685 · fetched Nov 12, 2026
- Pembrolizumab vs Topotecan in Patients With Small Cell Lung CancerPHASE2 · TERMINATED · started May 20, 2017ClinicalTrials.gov NCT02963090 · fetched Nov 12, 2026
- A Study of Androgen Annihilation in High-Risk Biochemically Relapsed Prostate CancerPHASE3 · COMPLETED · started Mar 6, 2017ClinicalTrials.gov NCT03009981 · fetched Nov 12, 2026
- Comparing an Operation to Monitoring, With or Without Endocrine Therapy (COMET) Trial For Low Risk DCISNA · ACTIVE_NOT_RECRUITING · started Feb 22, 2017ClinicalTrials.gov NCT02926911 · fetched Nov 12, 2026
- Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in CancerNA · COMPLETED · started Dec 13, 2016ClinicalTrials.gov NCT02744092 · fetched Nov 12, 2026
- A Study of Nivolumab +/- Nab-paclitaxel in Non-small Cell Lung CancerPHASE2 · TERMINATED · started Dec 1, 2016ClinicalTrials.gov NCT02967133 · fetched Nov 12, 2026
- Optimal Sequencing of Pembrolizumab (MK-3475) and Standard Platinum-based Chemotherapy in First-Line NSCLCPHASE2 · COMPLETED · started Mar 1, 2016ClinicalTrials.gov NCT02591615 · fetched Nov 12, 2026
- PALbociclib CoLlaborative Adjuvant StudyPHASE3 · ACTIVE_NOT_RECRUITING · started Aug 1, 2015ClinicalTrials.gov NCT02513394 · fetched Nov 12, 2026